Overactive bladder pharmacotherapy: what does the future hold? - Wikidata - wikimedia - TriplyDB

Overactive bladder pharmacotherapy: what does the future hold?

Overactive bladder pharmacotherapy: what does the future hold?

http://www.wikidata.org/entity/Q36815277

about

Research Findings on Overactive Bladder Trospium chloride treatment of overactive bladder

P2860

Q26801459-9C14CB82-3F0E-4376-B171-30F3839F9016 Q28308162-5E5F958B-0A0A-4888-95C8-CB98FADB27E1

P2860

Overactive bladder pharmacotherapy: what does the future hold?

http://www.wikidata.org/entity/Q36815277

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

2007年论文

@zh

2007年论文

@zh-cn

name

Overactive bladder pharmacotherapy: what does the future hold?

@ast

Overactive bladder pharmacotherapy: what does the future hold?

@en

type

label

Overactive bladder pharmacotherapy: what does the future hold?

@ast

Overactive bladder pharmacotherapy: what does the future hold?

@en

prefLabel

Overactive bladder pharmacotherapy: what does the future hold?

@ast

Overactive bladder pharmacotherapy: what does the future hold?

@en

P1433

Q36815277-966DDEB6-1F55-45A3-ABDD-FD1343B718EA

P1476

Q36815277-64A2DF1A-FD03-43DA-84E6-AC1850E603B0

P2093

Q36815277-749F6757-E3B5-46C2-9C71-740830CB40A2

P2860

Q36815277-34673589-FF6D-42B0-A8C1-016A5CB6927F

Q36815277-3C664E49-8D32-4102-968E-5D6EE0BCD969

Q36815277-42CC684C-C8C4-4F62-A10E-2BCEC35E729F

Q36815277-7798C9A4-4505-4D11-8F1B-D2CE287BF96D

Q36815277-7A82CDFC-CC37-4C32-9E99-BEB3C373FDBF

Q36815277-7FEE3EBC-5329-4F83-8E3D-AAB24CE5CA1B

Q36815277-976056A7-EBD7-4FDB-A3D0-A9DEA81A4450

Q36815277-EDF05720-999F-4069-8F8B-DA3DB1AA22CB

P304

Q36815277-A8009702-F2FF-4F61-9F96-E987B67B93B6

P31

Q36815277-D5C6148A-A4AB-485E-A5E6-C88D48C5EFD9

P356

Q36815277-C01CD06B-C14C-4397-BC8D-FCA0D32DEBB1

P478

Q36815277-1C212FE3-D484-41AC-8FD0-D207FA82BE39

P577

Q36815277-F00EC0C4-CD75-4A65-A3A1-04DD6C80EB74

P698

Q36815277-5EEBDBE1-AF15-4FAA-86A0-8885C655CC40

P921

Q36815277-76B330D7-9E15-4861-9A9B-92B6B01E408B

P356

J.1464-410X.2007.06697.X

P1433

BJU International

P1476

Overactive bladder pharmacotherapy: what does the future hold?

@en

P2093

Roger R Dmochowski

http://www.w3.org/2001/XMLSchema#string

P2860

Intravesical capsaicin and resiniferatoxin therapy: spicing up the ways to treat the overactive bladder.

Darifenacin, an M3 selective receptor antagonist, is an effective and well-tolerated once-daily treatment for overactive bladder.

Systemic capsaicin treatment impairs the micturition reflex in the rat.

Reduced perception of urgency in treatment of overactive bladder with extended-release tolterodine.

Randomized, double-blind placebo- and tolterodine-controlled trial of the once-daily antimuscarinic agent solifenacin in patients with symptomatic overactive bladder.

Randomized study of testosterone gel as adjunctive therapy to sildenafil in hypogonadal men with erectile dysfunction who do not respond to sildenafil alone.

Intravesical resiniferatoxin for the treatment of interstitial cystitis: a randomized, double-blind, placebo controlled trial.

Effects of spinal cord injury on neurofilament immunoreactivity and capsaicin sensitivity in rat dorsal root ganglion neurons innervating the urinary bladder.

P304

13-16

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1464-410X.2007.06697.X

http://www.w3.org/2001/XMLSchema#string

P478

99 Suppl 3

http://www.w3.org/2001/XMLSchema#string

P577

2007-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

17488368

http://www.w3.org/2001/XMLSchema#string

P921

pharmacotherapy